Related Experiment Video

Updated: Jun 3, 2026

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
08:17

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major

Published on: October 28, 2022

CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania

Neetu Srivastava1, Raki Sudan, Bhaskar Saha

  • 1National Centre for Cell Science, Ganeshkhind, Pune 411007, India.

Journal of Immunology (Baltimore, Md. : 1950)
|April 8, 2011
PubMed

Insights

CD40 signaling controls immune responses to Leishmania major by regulating dual-specificity MAPK phosphatases (MKPs). Targeting MKP-1 and MKP-3 offers a novel strategy to enhance anti-leishmanial immunity and combat infection.

Area of Science:

  • Immunology
  • Molecular Biology
  • Parasitology

Background:

  • Macrophage CD40 signaling dictates immune outcomes in Leishmania major infection, influencing IL-10 and IL-12 production.
  • p38 MAPK and ERK1/2 pathways, crucial for immune responses, are regulated by dual-specificity MAPK phosphatases (MKPs).

Purpose of the Study:

  • To investigate the role of CD40 in regulating MKP-1 and MKP-3 expression and activity during Leishmania major infection.
  • To determine how CD40-mediated regulation of MKPs impacts downstream signaling pathways and anti-leishmanial functions.

Main Methods:

  • Analysis of MKP-1 and MKP-3 expression and activity in macrophages infected with Leishmania major.
  • Investigating the effect of CD40 on p38 MAPK and ERK1/2 phosphorylation.
  • Utilizing triptolide and short hairpin RNA to inhibit MKP-1, and lentiviral overexpression to modulate MKP-3.
  • Assessing anti-leishmanial functions and protection in susceptible BALB/c mice.

Main Results:

  • MKP-1 expression and activity increased, while MKP-3 decreased in Leishmania major-infected macrophages.
  • CD40 differentially regulated MKP-1 and MKP-3, reciprocally controlling p38 MAPK and ERK1/2 phosphorylation.
  • Inhibition of MKP-1 or overexpression of MKP-3 enhanced anti-leishmanial functions and reduced disease severity in mice.

Conclusions:

  • CD40 reciprocally regulates MKP-1 and MKP-3, which are critical for modulating CD40-driven anti-leishmanial immune responses.
  • These findings reveal a parasite immune evasion strategy involving MKP regulation.
  • Targeting MKP-1 and MKP-3 presents a promising therapeutic avenue for redirecting CD40-mediated immunity against Leishmania major.

More Related Videos

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host09:53

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 27, 2010

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites10:01

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites

Published on: March 16, 2018

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...